Major depressive disorder affects almost 40% more people in the 7MM than previously estimated
ChariotMS will be the first multiple sclerosis (MS) clinical trial to include people who can’t...
Pfizer and BioNTech have announced results from an in vitro study.
Synthetic control arms could transform clinical development as they allow companies to overcome in the...